Evidence map›Paper›PMID 26122175›Full record

ArticleClinical immunology (Orlando, Fla.)2015

Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders.

Pauline A van Schouwenburg, Emma E Davenport, Anne-Kathrin Kienzler, Ishita Marwah, Benjamin Wright, Mary Lucas, Tomas Malinauskas, Hilary C Martin, WGS500 Consortium, Helen E Lockstone and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Case Report: Diagnosis ofFrontiers in medicine · 2025
    Article
  11. Article
  12. Case Report: A novelFrontiers in immunology · 2025
    Article
  13. Exploring gastric cancer genetics: A turning point in common variable immunodeficiency.The journal of allergy and clinical immunology. Global · 2024
    Article
  14. Review
  15. IgDPathogens (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Epigenetic Alterations in Inborn Errors of Immunity.Journal of clinical medicine · 2022
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Pauline A van SchouwenburgNuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Emma E DavenportNuffield Department of Medicine, University of Oxford, Oxford, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Anne-Kathrin KienzlerNuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Ishita MarwahNuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Benjamin WrightNuffield Department of Medicine, University of Oxford, Oxford, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Mary LucasNuffield Department of Medicine, University of Oxford, Oxford, UK.
Tomas MalinauskasCold Spring Harbor Laboratory, W. M. Keck Structural Biology Laboratory, Cold Spring Harbor, NY 11724, USA.
Hilary C MartinNuffield Department of Medicine, University of Oxford, Oxford, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
WGS500 Consortium
Helen E LockstoneWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Jean-Baptiste CazierWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK; Centre for Computational Biology, University of Birmingham, Haworth Building, B15 2TT Edgbaston, UK.
Helen M ChapelNuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Julian C KnightNuffield Department of Medicine, University of Oxford, Oxford, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. Electronic address: julian@well.ox.ac.uk.
Smita Y PatelNuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK. Electronic address: smita.patel@ndm.ox.ac.uk.
Centre for Human Genetics · GBJohn Radcliffe Hospital · GBUniversity of Oxford · GBCold Spring Harbor Laboratory · US

Funding

Cancer Research UK 16459European Research Council 281824Medical Research Council MC_UU_12010/6Wellcome Trust 090532Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Common Variable Immunodeficiency Disorders (CVIDs) are the most prevalent cause of primary antibody failure. CVIDs are highly variable and a genetic causes have been identified in <5% of patients. Here, we performed whole genome sequencing (WGS) of 34 CVID patients (94% sporadic) and combined them with transcriptomic profiling (RNA-sequencing of B cells) from three patients and three healthy controls. We identified variants in CVID disease genes TNFRSF13B, TNFRSF13C, LRBA and NLRP12 and enrichment of variants in known and novel disease pathways. The pathways identified include B-cell receptor signalling, non-homologous end-joining, regulation of apoptosis, T cell regulation and ICOS signalling. Our data confirm the polygenic nature of CVID and suggest individual-specific aetiologies in many cases. Together our data show that WGS in combination with RNA-sequencing allows for a better understanding of CVIDs and the identification of novel disease associated pathways.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAdultB-Cell Activation Factor ReceptorB-LymphocytesCase-Control StudiesChildChild, PreschoolCommon Variable ImmunodeficiencyFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGenomeHumansIntracellular Signaling Peptides and ProteinsMaleAdaptor Proteins, Signal TransducingB-Cell Activation Factor ReceptorIntracellular Signaling Peptides and ProteinsLRBA protein, humanNLRP12 protein, humanRNA, MessengerTNFRSF13B protein, humanTNFRSF13C protein, humanTransmembrane Activator and CAML Interactor ProteinB-cellCommon variable immunodeficiencyPolygenicTranscriptomeWhole genome sequencing

Identifiers

PMID26122175
PMCPMC4601528
OpenAlexW2097135007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.